In this episode, Sumeet Ambarkhane, the Chief Medical Officer at Alligator Bioscience, which focuses on tumor-targeted immunotherapies, talks about the work his company does in creating new cancer treatments that help the immune system target tumors. He discusses their work on a drug called metazolamab and shares stories from his career, including a big success he had with a special antibody treatment at MorphoSys—a commercial-stage biopharmaceutical company that develops innovative medicines.

He also talks about important things to consider when hiring people and how the field of developing new medical treatments is changing.

Here's what you're in for:

00:50 AI and Industry Trends

01:36 How Sumeet's career in Biotech Started

02:45 Sumeet's Professional Journey and Current Role

05:08 Hard Parts and New Ideas at Alligator Bioscience

14:42 Career Reflections and Lessons Learned

34:30 Tips on Hiring and Making a Good Team

45:29 Wrapping Up and gratitude

About Sumeet Ambarkhane

Sumeet Ambarkhane has been the Chief Medical Officer at Alligator Bioscience and part of the senior management since 2022. He is an experienced clinical development physician with a strong expertise in Oncology, Hemato-oncology, and Immunology Drug Development. He has in-depth experience in Medical Monitoring, Clinical Program Management, Regulatory Interactions, Translational Research, and Drug Safety.

He exhibits high-impact leadership at the organizational level and maintains a global network of Key Opinion Leaders (KOLs) and drug development experts.

Connect with Sumeet Ambarkhane:

LinkedIn: https://www.linkedin.com/in/sumeetambarkhane/?originalSubdomain=de

Website: https://alligatorbioscience.se/en/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://www.discera-search.com/